We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+5.06%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$8.36B
AUM Growth
+$811M
(+11%)
Cap. Flow
+$513M
Cap. Flow
% of AUM
6.13%
Top 10 Holdings %
Top 10 Hldgs %
9.6%
Holding
2,400
New
687
Increased
686
Reduced
568
Closed
456
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Gold Miners ETF
GDX
|
+$87.3M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$58.8M |
| 3 |
Wells Fargo
WFC
|
+$50M |
| 4 |
Archer Daniels Midland
ADM
|
+$46.7M |
| 5 |
Southern Company
SO
|
+$46.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$79.7M |
| 2 |
Cigna
CI
|
+$69.1M |
| 3 |
iShares MSCI Taiwan ETF
EWT
|
+$46.8M |
| 4 |
Caterpillar
CAT
|
+$42.7M |
| 5 |
DXC Technology
DXC
|
+$40M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 18.52% |
| 2 | Technology | 13.89% |
| 3 | Financials | 12.78% |
| 4 | Industrials | 11.24% |
| 5 | Healthcare | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VTLE
876
DELISTED
Vital Energy
VTLE
| $1.3M | 0.02% |
+7,952
| New | +$1.39M |
|
877
STAAR Surgical
STAA
$1.16B
| $1.3M | 0.02% |
27,000
-13,700
| -34% | -$561K |
|
878
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.65B
| $1.29M | 0.02% |
18,321
-474,449
| -96% | -$33.7M |
|
|
TWO
879
Two Harbors Investment
TWO
$1.27B
| $1.29M | 0.02% |
21,673
-17,581
| -45% | -$1.1M |
|
|
GHDX
880
DELISTED
Genomic Health, Inc.
GHDX
| $1.29M | 0.02% |
18,400
-10,735
| -37% | -$628K |
|
881
SL Green Realty
SLG
$3.88B
| $1.29M | 0.02% |
13,656
-49,097
| -78% | -$4.85M |
|
|
DCPH
882
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $1.29M | 0.02% |
33,278
+5,221
| +19% | +$193K |
|
883
Travere Therapeutics
TVTX
$5.33B
| $1.29M | 0.02% |
44,756
+4,115
| +10% | +$118K |
|
|
ESPR
884
DELISTED
Esperion Therapeutics
ESPR
| $1.28M | 0.02% |
28,808
-13,940
| -33% | -$640K |
|
885
Zurn Elkay Water Solutions
ZWS
$8.07B
| $1.28M | 0.02% |
86,046
+59,681
| +226% | +$850K |
|
886
Kaiser Aluminum
KALU
$2.67B
| $1.27M | 0.02% |
+11,639
| New | +$1.26M |
|
|
CNR
887
DELISTED
Cornerstone Building Brands, Inc.
CNR
| $1.27M | 0.02% |
83,701
+20,758
| +33% | +$346K |
|
888
NiSource
NI
$22.4B
| $1.27M | 0.02% |
50,790
-151,269
| -75% | -$4M |
|
889
Lamb Weston
LW
$6.82B
| $1.26M | 0.02% |
+18,896
| New | +$1.3M |
|
890
Park Hotels & Resorts
PK
$2.97B
| $1.26M | 0.02% |
+38,312
| New | +$1.24M |
|
891
Globe Life
GL
$13.5B
| $1.25M | 0.01% |
14,383
-70,287
| -83% | -$6.07M |
|
892
Avanos Medical
AVNS
$1.17B
| $1.25M | 0.01% |
18,187
-10,893
| -37% | -$701K |
|
893
Vishay Intertechnology
VSH
$5.86B
| $1.25M | 0.01% |
61,218
-58,500
| -49% | -$1.38M |
|
|
EFOR
894
Everforth Inc
EFOR
$845M
| $1.24M | 0.01% |
+15,761
| New | +$1.36M |
|
895
NeoGenomics
NEO
$1.81B
| $1.24M | 0.01% |
81,000
+52,500
| +184% | +$726K |
|
896
Dover
DOV
$27.2B
| $1.23M | 0.01% |
+13,893
| New | +$1.15M |
|
897
Darling Ingredients
DAR
$9.93B
| $1.23M | 0.01% |
+63,589
| New | +$1.25M |
|
898
Brookfield
BN
$102B
| $1.23M | 0.01% |
+77,198
| New | +$1.17M |
|
|
LSXMA
899
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $1.23M | 0.01% |
39,098
-16,943
| -30% | -$568K |
|
900
Lands' End
LE
$361M
| $1.23M | 0.01% |
+69,779
| New | +$1.64M |
|
Similar funds
Squarepoint's Q3 2018 Portfolio in Review
As of Q3 2018, Squarepoint held 2,400 positions worth $8.36B, up 11% from $7.55B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
Squarepoint deployed $513M of net new capital in Q3 2018, opening 687 new positions and adding to 686 existing holdings. Its largest new stake was VanEck Gold Miners ETF: 4,374,139 shares worth $81M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Cigna, an estimated $69.1M trimmed.
- Squarepoint's largest Q3 2018 buy was VanEck Gold Miners ETF: 4,374,139 shares worth $81M.
- Squarepoint added most to iShares Core MSCI Emerging Markets ETF in Q3 2018, an estimated $58.8M increase.
- Squarepoint's biggest Q3 2018 reduction was Cigna, cutting an estimated $69.1M.
- Squarepoint fully exited Vanguard FTSE Emerging Markets ETF in Q3 2018, selling an estimated $79.7M.
- Squarepoint's ten largest holdings make up 9.6% of its $8.36B portfolio in Q3 2018.
- Squarepoint opened 687 new positions and closed 456 in Q3 2018.
- Squarepoint's portfolio value rose 11% quarter-over-quarter to $8.36B.
Based on Squarepoint's 13F filing for Q3 2018, filed 14 Nov 2018.